Cambridge Healthtech Institute’s 8th Annual

Cell Therapy CMC and Analytics

August 14-15, 2023

 

Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representatives. Topics include CMC regulatory requirements, product and process characterization, potency assays development, quality of starting materials, and commerical scale challenges, with examples coming from the fields of CAR Ts, CAR-NKs, IPSCs, gamma deltas and TILs.

 

Coverage will include, but is not limited to:

 

  • Standards and regulatory expectations
  • Analytical methods for gene edited cell-based therapies
  • Manufacturing strategies for gene edited cell-based therapies
  • CMC strategies for cell-based therapies – preclinical to Phase III
  • Digitalization and AI in cell therapy analytics
  • Lifecycle management
  • Raw materials and adventitious agent testing
  • Monitoring quality across the process
  • Process analytics for cell therapies
  • Comparability strategies following process change – late-stage, post-approval, tech transfer
  • Quality control
  • Process development
  • In-process controls – rapid sterility testing
  • Formulation

 

The deadline for priority consideration is February 3, 2023.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7837-651-303

Email: dbarry@healthtech.com

 

For sponsorship information, please contact:

Companies A-M

Phillip Zakim-Yacouby

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-247-1815

Email: philzy@cambridgeinnovationinstitute.com

 

Companies N-Z

Aimee Croke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-292-0777

Email: acroke@cambridgeinnovationinstitute.com